JSR Life Sciences, LLC a JSR Life Sciences company, has announced plans to enter into a subcontract with Novel351k to co-develop three biosimilar programs that address a wide range of hard-to-treat diseases.

For details, please see the announcement from JSR Life Sciences LLC on URL.
https://news.jsrlifesciences.com/222994-similis-bio-partners-with-novel351k-to-develop-multiple-biosimilar-programs-targeting-cancer-and-autoimmune-diseases